Archives: : Small Molecule

Alchemite™ validated for global pharma data in peer-reviewed study

  • on June 29, 2021

Read more

Optimising kinase profiling programs with Optibrium and Genentech

  • on June 2, 2021

Read more

Discovering a new drug compound with the Open Source Malaria project

  • on February 1, 2021

OSM – drug development | Successful design of new antimalarial compounds

Read more

Innovate UK Funded Project Produces Next-Generation AI Drug Discovery Platform

  • on December 3, 2020

Read more

Predicting pharmacokinetics with Optibrium and AstraZeneca

  • on November 11, 2020

Read more

Launch of Cerella, a novel AI platform for active learning in drug discovery

  • on November 2, 2020

Read more

Practical applications of deep learning to impute heterogeneous drug discovery data

  • on June 22, 2020

Read more

Imputation versus prediction: applications in machine learning for drug discovery

  • on April 6, 2020

Read more
Anopheles mosquito

Optibrium and Intellegens achieve further success in Open Source Malaria initiative with in vitro validation of in silico generated compound

  • on April 1, 2020

Read more

Drug Discovery: Novel deep neural network imputation predicts bioactivity from sparse data

  • on January 16, 2020

Read more